Diabetes mellitus - risk factor for atrial fibrillation. Potential therapeutic implications

被引:0
|
作者
Meinertz, T. [1 ]
Sydow, K. [2 ]
机构
[1] Deutsch Herzstiftung, D-60322 Frankfurt, Germany
[2] Univ Herzzentrum Hamburg, Hamburg, Germany
关键词
Metabolic disorder; Glycemic control; Cardiac arrhythmia; Cardiovascular events; Prognosis; METABOLIC SYNDROME; PREVALENCE; OBESITY; COHORT; ADULTS; IMPACT;
D O I
10.1007/s00059-014-4085-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The relationship between atrial fibrillation and diabetes mellitus type 2 is controversial, and various studies have demonstrated conflicting results. However, the majority of larger prospective studies published during recent years demonstrated a positive correlation. After multivariate adjustment diabetes increased the risk for atrial fibrillation at least two fold. This combination is associated with substantially increased risks of death and cardiovascular events (stroke and heart failure). Atrial fibrillation in patients with diabetes mellitus type 2 identifies individuals who are likely to obtain greater benefits from glycemic control and anticoagulants as well as antihypertensive therapy.
引用
收藏
页码:320 / 324
页数:5
相关论文
共 50 条
  • [31] Streptozotocin-induced diabetes mellitus increases the risk for atrial fibrillation
    Ziberna, K.
    Recalde, A.
    Carnicer, R.
    Casadei, B.
    DIABETOLOGIA, 2016, 59 : S12 - S12
  • [32] Influence of factor VII-323 Del/Ins polymorphism in the prothrombotic state in atrial fibrillation. Implications in ischaemic stroke risk
    Roldan, V.
    Marin, F.
    Gonzalez-Conejero, R.
    Corral, J.
    Garcia-Honrubia, A.
    Lip, G. Y.
    Vicente, V.
    EUROPEAN HEART JOURNAL, 2007, 28 : 76 - 77
  • [33] Therapeutic management of non-valvular atrial fibrillation. Update 2013
    Bode, K.
    Sommer, P.
    Bollmann, A.
    Hindricks, G.
    HERZ, 2013, 38 (07) : 743 - 755
  • [34] Lean body mass is the predominant anthropometric risk factor for atrial fibrillation. A Danish cohort study
    Frost, L.
    Overvad, K.
    Tjonneland, A.
    Fenger-Gron, M.
    EUROPEAN HEART JOURNAL, 2016, 37 : 288 - 288
  • [35] Frailty syndrome and adherence to therapeutic recommendations in elderly patients with atrial fibrillation.
    Lomper, K.
    Michajlow, A.
    Chudiak, A.
    Wleklik, M.
    Lisiak, M.
    Uchmanowicz, I.
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2018, 17 : 91 - 92
  • [36] Aerobic Training Reduces Stroke Risk in Patients With Atrial Fibrillation.
    Tseng, Benjamin
    Arce-Esquivel, Arturo
    Sarma, Satyam
    STROKE, 2019, 50
  • [37] Atrial fibrillation maybe a potential risk factor for pulmonary embolism
    Bin Waleed, Khalid
    Xia Yunlong
    Yin Xiaomeng
    Chang Dong
    Guan Xu Meng
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (16) : C84 - C84
  • [38] Preventing Atrial Fibrillation With Treatments for Diabetes Mellitus
    Granger, Christopher B.
    Mahaffey, Kenneth W.
    CIRCULATION, 2020, 141 (15) : 1235 - 1237
  • [39] Improving risk stratification in atrial fibrillation: Renal dysfunction and risk of thromboembolism and death in nonvalvular atrial fibrillation. The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study.
    Go, AS
    Hylek, EM
    Udaltsova, N
    Chang, YC
    Jensvold, NG
    Henault, LE
    Singer, DE
    CIRCULATION, 2004, 109 (07) : E92 - E92
  • [40] The Therapeutic Potential of MicroRNAs in Atrial Fibrillation
    Xu, Xiaona
    Zhao, Zhiqiang
    Li, Guangping
    MEDIATORS OF INFLAMMATION, 2020, 2020